AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 125 filers reported holding AUDENTES THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,195,424 | +113.0% | 19,977 | 0.0% | 0.01% | +100.0% |
| Q3 2019 | $561,154 | -25.8% | 19,977 | 0.0% | 0.01% | -25.0% |
| Q2 2019 | $756,327 | +13.1% | 19,977 | +16.5% | 0.01% | 0.0% |
| Q1 2019 | $668,920 | +83.0% | 17,143 | 0.0% | 0.01% | +60.0% |
| Q4 2018 | $365,489 | -38.4% | 17,143 | +14.4% | 0.01% | -16.7% |
| Q3 2018 | $593,415 | +3.6% | 14,989 | 0.0% | 0.01% | -14.3% |
| Q2 2018 | $573,000 | +140.8% | 14,989 | +89.0% | 0.01% | +133.3% |
| Q1 2018 | $238,000 | -4.0% | 7,930 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $248,000 | – | 7,930 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 294,013 | $11,131,000 | 9.27% |
| GREAT POINT PARTNERS LLC | 1,922,937 | $72,802,000,000 | 8.08% |
| Versant Venture Management, LLC | 553,916 | $20,971,260,000 | 6.11% |
| Foresite Capital Management III, LLC | 315,331 | $11,938,000 | 3.92% |
| Casdin Capital, LLC | 965,000 | $36,534,900,000 | 3.42% |
| Sofinnova Investments, Inc. | 933,640 | $35,348,000 | 3.25% |
| Opaleye Management Inc. | 280,000 | $10,601,000 | 3.23% |
| Redmile Group, LLC | 2,972,167 | $112,526,000 | 3.18% |
| PFM Health Sciences, LP | 3,228,679 | $122,238,000 | 2.32% |
| Eversept Partners, LP | 159,526 | $6,039,654 | 1.69% |